From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.

Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

University of Udine, Via Palladio 8, Udine 33100, Italy hDepartment of Medical Oncology, CRO Aviano, National Cancer Institute, IRCCS, Via Franco Gallini 2, Aviano, Pordenone 33081, Italy iDepartment ...

The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal antibody with the cytotoxicity of a potent small molecule drug, ADCs can ...

Alloy Therapeutics Inc. ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

In cancer, antibodies can target tumour cells directly for destruction (e.g., antibody-drug conjugates) or amplify the immune response (e.g., ADCC, CDC, bispecifics). In autoimmune diseases ...

These biological therapeutics can be immunogenic, resulting in anti-drug antibody formation which leads to loss of response. Fully human biological agents, such as the anti-tumour necrosis factor α ...

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...

Weight-loss medication has taken the world by storm and helped many overweight people. But for some, significant weight loss ...